Potential Applications of Hyaluronans in Orthopaedics

Goa KL, Benfield P. Hyaluronic acid: a review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 1994; 47 (3): 536–66 Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J 1993; 7 (13): 1233–41 Altman RD. Status of hyaluronan supplementation therapy in osteoarthritis. Curr Rheum Rep 2003; 5 (1): 7–14 Hamburger MI, Lakhanpal S, Mooar PA, et al. Intra-articular hyaluronans: a review of product-specific safety profiles. Semin Arthritis Rheum 2003; 32 (5): 296–309 Abatangelo G, O’Regan M. Hyaluronan: biological role and function in articular joints. Eur J Rheum Inflamm 1995; 15 (1): 9–16 Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 2002; 32 (1): 10–37 Binkley JM, Peat M. The effects of immobilization on the ultrastructure and mechanical properties of the medial collateral ligament of rats. Clin Orthop Relat Res 1986; 203: 301–8 Säämänen AM, Tammi M, Jurvelin J, et al. Proteoglycan alterations following immobilization and remobilization in the articular cartilage of young canine knee (stifle) joint. J Orthop Res 1990; 8 (6): 863–73 Di Marco C, Letizia GA. Hyaluronic acid in the treatment of pain due to knee joint immobilization: a controlled clinical study. Clin Drug Invest 1995; 10 (4): 191–7 Zattoni G, Cabrioli A, Brunelli G, et al. Efficacy and tolerability of hyaluronic acid in acute knee injury: a controlled clinical study. Eur J Rheumatol Inflamm 1995; 15 (1): 63–9 Wang CW, Gao LH, Jin XY, et al. Clinical study of sodium hyaluronate as supplementary treatment for comminution fracture of ankle joints. [in Chinese] Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2002; 16 (1): 21–2 Dai GF, Tang JW, Wang SJ, et al. Efficacy of intra-articular injection of sodium hyaluronate in post-operation treatment of the knee [in Chinese]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2002; 16 (1): 16–8 Solchaga LA, Yoo JU, Lundberg M, et al. Hyaluronan-based polymers in the treatment of osteochondral defects. J Orthop Res 2000; 18: 773–80 Marcacci M, Kon E, Zaffagnini S, et al. Autologous chondrocyte transplantation on 3-dimensional hyaluronic acid support (Hyalograft C): histologic evaluation at 1 year follow up. Proceedings of the 70th Annual Meeting of the American Academy of Orthopaedic Surgeons; 2003 Feb 5–9; New Orleans (LA) Takahashi K, Hashimoto S, Kubo T, et al. Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 2000; 27 (7): 1713–20 Solchaga LA, Goldberg VM, Caplan AI. Experimental models of cartilage repair: cartilage regeneration using principles of tissue engineering. Clin Orthop 2001; 391S: S161–70 Espallargues M, Pons JM. Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review. Int J Technol Assess Health Care 2003; 19 (1): 41–56 Kelly MA, Goldberg VM, Healy WL, et al. Osteoarthritis and beyond: a consensus on the past, present and future of hyaluronans in orthopedics. Orthopedics 2003; 26: 1064–79 Maheu E, Ayral X, Dougados M. A hyaluronan preparation (500–730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan. Int J Clin Pract 2002; 56 (10): 804–13 Yamamoto R, Namiki O, Iwata H, et al. Randomized comparative study of sodium hyaluronate (SPH) on periarthritis scapulohumeralis. Jpn J Clin Pharmacol Ther 1988; 19 (4): 717–33 Ueno Y, Kuramoto K, Konno N, et al. Investigation on result of use after launch of ARTZ and ARTZ Dispo: evaluation on the efficacy, safety and utility in the medication for osteoarthritis of the knee and periarthritis of the shoulder. Jpn J Pharmacol Ther 1995; 23 (8): 2151–70 Rovetta G, Monteforte P. Intraarticular injection of sodium hyaluronate plus steroid versus steroid in adhesive capsulitis of the shoulder. Int J Tissue React 1988; 20 (4): 125–30 Ramonda R, Franceschini M, Leardini G. Treatment of shoulder periarthritis with hyaluronic acid. Revista Ital Biol Med 1998; 1 (2 Suppl.): 51S Leardini G, Perbellini A, Franceschini M, et al. Intra-articular injections of hyaluronic acid in the treatment of painful shoulder. Clin Ther 1988; 10 (5): 521–6 Itokazu M, Matsunaga T. Clinical evaluation of high-molecular-weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder. Clin Ther 1995; 17 (5): 946–55 Raynauld J-P, Choquette D, Haraoui B, et al. Hylan vs triamcinolone acetonide injection for acute supraspinatus tendinitis: early report of a randomized controlled trial. Arthritis Rheum 1994; 37 Suppl. 9: 346S Fernandez-Palazzi F, Viso R, Boadas A, et al. Intra-articular hyaluronic acid in the treatment of haemophilic chronic arthropathy. Haemophilia 2002; 8 (3): 375–81 Bragantini A, Molinaroli F. A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Curr Ther Res 1994; 55 (3): 319–30 Lanzotti SB, Machado MB, Nascimento RA, et al. Intra-articular sodium hyaluronate in unilateral coxofemoral osteoarthritis treatment [abstract]. Arthritis Rheum 2000; 43 Suppl.: S336 Brasington R, Reinus W. A pilot study of arthrographically-guided intraarticular injection of hylan for osteoarthritis of the hip. Proceedings of the XIV European League Against Rheumatism Congress; 1999 Jun 6–11; Glasgow, 124 Chevalier X, Conrozier T, Bertin P, et al. Treatment of patients with symptomatic hip OA: a pilot study with intra-articular hylan G-F 20 (Synvisc). Arthritis Rheum 2000; 44 Suppl.: 384S Brocq O, Tran G, Breuil V, et al. Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20: an open-label study in 22 patients. Joint Bone Spine 2002; 69 (4): 388–91 Vad VB, Sakalkale D, Sculco TP, et al. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 2003; 84: 1224–6 Kopp S, Wenneberg B, Haraldson T, et al. The short-term effect of intra-articular injections of sodium hyaluronate and corticosteroid on temporomandibular joint pain and dysfunction. J Oral Maxillofac Surg 1985; 43 (6): 429–35 Kopp S, Akerman S, Nilner M. Short-term effects of intra-articular sodium hyaluronate, glucocorticoid, and saline injections on rheumatoid arthritis of the temporomandibular joint. J Craniomandib Disord 1991; 5 (4): 231–8 Bertolami CN, Gay T, Clark GT, et al. Use of sodium hyaluronate in treating temporomandibular joint disorders: a randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg 1993; 51 (3): 232–42 Hepguler S, Akkoc YS, Pehlivan M, et al. The efficacy of intra-articular sodium hyaluronate in patients with reducing displaced disc of the temporomandibular joint. J Oral Rehabil 2002; 29 (1): 80–6 Shi ZD, Yang F, Zhang JY, et al. Randomized controlled trial of sodium hyaluronate for degenerative disorders of the temporomandibular joint [in Chinese]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2002; 16 (1): 11–5 Alpaslan GH, Alpaslan C. Efficacy of temporomandibular joint arthrocentesis with and without injection of sodium hyaluronate in treatment of internal derangements. J Oral Maxillofac Surg 2001; 59 (6): 613–8 McCain JP, Balazs EA, de la Rua H. Preliminary studies on the use of a viscoelastic solution in arthroscopic surgery of the temporomandibular joint. J Oral Maxillofac Surg 1989; 47 (11): 1161–8 Guarda-Nardini L, Tito R, Staffieri A, et al. Treatment of patients with arthrosis of the temporomandibular joint by infiltration of sodium hyaluronate: a preliminary study. Eur Arch Otorhinolaryngol 2002; 259: 279–84 Mohamed Y, Schumacher HR. Can joints other than knees be safely and successfully treated with intra-articular hyaluronate? Pilot studies on osteo-arthritis of the first MC-C joint. J Rheumatol 2001; 28 (63 Suppl.): 7S Srejic U, Calvillo O, Kabakibou K. Viscosupplementation: a new concept in the treatment of sacroiliac joint syndrome: a preliminary report of four cases. Reg Anesth Pain Med 1999; 24 (1): 84–8 Athanassiou-Metaxa M, Koussi A, Economou M, et al. Chemical synoviorthesis with rifampicine and hyaluronic acid in haemophilic children. Haemophilia 2002; 8 (6): 815–6 Data on file, Sanofi-Synthelabo Inc., 2003 Migliore A, Martin LS, Alimonti A, et al. Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 2003; 11 (4): 305–6 Genzyme Biosurgery clinical trials summary [online]. Available from URL: http://www.genzymebiosurgery.com/corp/research/gzbx_p_re_clintrials.asp [Accessed 2005 Aug 10] Salk RS, Chang TJ, D’Costa WF, et al. Use of sodium hyaluronate (Hyalgan®) in treating osteoarthritis of the ankle: a randomized, double-blind, placebo-controlled clinical trial [abstract]. Proceedings of the American College of Foot and Ankle Surgeons Annual Scientific Conference; 2004 Feb 11–15, San Diego (CA) Shi Z, Guo C, Awad M. Hyaluronate for temporomandibular joint disorders (Cochrane Review). Cochrane Database Syst Rev 2003; (1): CD 002970 Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 2005 Mar; 13 (3): 216–24 Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 1998; 16 (4): 441–9 Guidolin DD, Ronchetti IP, Lini E, et al. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500–730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthritis Cartilage 2001; 9 (4): 371–81 Listrat V, Ayral X, Patarnello F, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997; 5 (3): 153–60 Pasquali Ronchetti I, Guerra D, Taparelli F, et al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology (Oxford) 2001; 40 (2): 158–69 Jubb RW, Piva S, Beinat L, et al. Structure modifying study of hyaluronan (500–730 KDa, Hyalgan) on osteoarthritis of the knee. Arthritis Rheum 2001; 44 Suppl.: 155S Punzi L, Schiavon F, Ramonda R, et al. Intra-articular hyaluronic acid in the treatment of inflammatory and noninflammatory knee effusions. Curr Ther Res 1988; 43 (4): 643–7 Möller I, Martí N. Chondroprotection: a wider concept? Preliminary clinical experience with hyaluronic acid (Hyalgan) in patients with rheumatoid arthritis. Osteoarthritis and Cartilage 1999; 7 Suppl.: 34 Miura T, Tanba S, Yoshizawa H, et al. High-molecular Na-hyaluronate intra-articular injection for the patients with rheumatoid arthritis combined osteoarthritis of the knee joint [in Japanese]. Igaku to Yakugaku 1993; 29 (4): 1061–71 Goto M, Hanyu T, Yoshio T, et al. Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial. Clin Exp Rheumatol 2001; 19 (4): 377–83 Tanaka N, Sakahashi H, Sato E, et al. Intra-articular injection of high molecular weight hyaluronan after arthrocentesis as treatment for rheumatoid knees with joint effusion. Rheumatol Int 2002; 22 (4): 151–4 Matsuno H, Yudoh K, Kondo M, et al. Biochemical effect of intra-articular injections of high molecular weight hyaluronate in rheumatoid arthritis patients. Inflamm Res 1999; 48 (3): 154–9